05:37 PM EDT, 04/26/2024 (MT Newswires) -- Stan Smith, Director, on April 25, 2024, executed a purchase for 147,492 shares in Maia Biotechnology ( MAIA ) for $299,409. Following the Form 4 filing with the SEC, Smith has control over a total of 1,005,060 shares of the company, with 1,005,060 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1878313/000112760224013488/xslF345X03/form4.xml